Companies Dominating the Antidepressants Landscape
- AbbVie Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Alkermes
- Sun Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- F. Hoffmann-La Roche Ltd.
- AstraZeneca PLC
- GlaxoSmithKline plc
- Bristol-Myers Squibb Company
Browse Key Market Insights with Data Illustration:
In the News
-
AbbVie Inc., submitted a supplemental New Drug Application (sNDA) for cariprazine (VRAYLAR) to the U.S. Food and Drug Administration (FDA) to treat major depressive disorder (MDD) in patients receiving existing antidepressants.
-
Alkermes, announced the receiving of Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) in response to its New Drug Application (NDA) for ALKS 5461 for the adjunctive treatment of major depressive disorder (MDD).
